Aramark

ARMK
Free primer · Steps 1–3 of 21Coverage as of 2026-Q2

Business Model


source: coverage-next-full ticker: ARMK company: Aramark step: 01 title: Business Model & Overview created: 2026-06-09

Step 01 — Business Model & Overview: ARMK (Aramark)

1. Business Model Summary

Aramark Corporation is a contract food services and facilities management company that manages food and support operations inside client-owned facilities under long-term service agreements. It is not a restaurant chain, a food manufacturer, or a staffing agency — it is an institutional services operator that takes over a client's dining hall, cafeteria, hospital kitchen, or arena concession stand and runs it on the client's behalf. [S1]

Revenue model: Aramark earns a service management fee plus reimbursement of direct costs (food, labor, supplies). Contract structures vary — some are "profit-and-loss" (Aramark keeps revenue, absorbs costs), others are "cost-plus" (client reimburses costs, Aramark charges a fee). The P&L model dominates in sports/entertainment and Business Industry; cost-plus is more common in healthcare and education. [S1]

2. Value-Chain Layer Map

CLIENT INSTITUTION
(University, Hospital, Stadium, Corporate Campus, Prison, Data Center)
       |
       | Long-term service contract (3–10 years typical)
       |
ARAMARK — SERVICE OPERATOR LAYER
  ├── Food Planning & Menu Design
  ├── Procurement (centralized — scale purchasing advantage)
  ├── Staffing & Training (hourly + management workforce)
  ├── Technology (POS, dietary management, digital ordering)
  ├── Facilities Services (cleaning, maintenance — mostly healthcare/B&I)
  └── Specialized Services (dietary counseling, sustainability programs)
       |
FOOD SUPPLY CHAIN
  ├── National broadline distributors (Sysco, US Foods)
  ├── Regional produce suppliers
  └── Direct manufacturer relationships (scale purchasing)

Aramark's position: Middle layer between food producers and institutional end-users. Revenue scales with meals served + services delivered. Pricing power comes from proprietary menus, dietary technology, and switching costs embedded in multi-year contracts.

3. Segment Structure [S1]

FSS United States (71% of FY2025 revenue — $13.2B)

Serves five client verticals:

  • Business Industry ($1.9B, +18% YoY): Corporate cafeterias, office campuses, technology parks. Fastest-growing sub-segment. Includes early revenues from Aramark Nexus (AI data center food/facilities services).
  • Education ($3.8B, +4.4%): K-12 schools, colleges and universities. Aramark holds ~18% of US college dining market (second only to Compass/Chartwells at ~19%).
  • Healthcare ($1.7B, +3.8%): Hospital food service, patient dining, retail cafeterias. Regulatory overlay (CMS, Joint Commission). RWJ Barnabas Health contract ramping June 2026 is a major new win.
  • Sports, Leisure & Corrections ($4.2B, +6.1%): Stadium/arena concessions (largest sub-segment by revenue), national park food service, correctional facility dining. Highly seasonal — H1 of calendar year heavy.
  • Facilities Other ($1.6B, -7.1%): Housekeeping and maintenance services. Decline reflects strategic exit of lower-margin accounts in FY2024.
FSS International (29% of FY2025 revenue — $5.3B)

Operations in 15+ countries: Canada (largest), Chile, Germany, Spain, UK, Ireland, China, among others. Organic growth +10.4% in FY2025 (includes FX headwind ~2-3%). Segment margin (3.7%) slightly below FSS US (5.4%) — reflects earlier-stage markets and FX pressure.

4. Revenue Model & Economics [S1][S2]

Component Typical Range
Revenue per contract type Mix of P&L (revenue-booking) and cost-plus
Gross margin ~8-9% (food cost ~28%, labor ~42%, other direct ~22%, leaving ~8-9% gross)
Operating margin ~4-5% — thin by design (institutional clients have pricing leverage)
EBITDA margin ~6.5-7%
Average contract length 3–10 years
Contract retention rate >90% (management guidance)
Net new business Targeting 4–5%+ per year

Key economics insight: Aramark's reported gross margin (~8.4%) looks misleadingly thin because it includes all direct service costs (food + labor + supplies) before the management fee gross-up. At the operating line, the 4–5% margin is where value accrues. The EBITDA margin of ~6.5-7% is more representative of cash earnings power.

5. Aramark Nexus — Strategic Growth Initiative [S3]

Aramark Nexus is the company's dedicated business serving AI hyperscaler data centers — providing food and facilities services to the massive campuses that AI infrastructure companies (Microsoft Azure, Google, Amazon AWS, etc.) are building. Per investor presentations, the largest client is expected to be a top global hyperscaler. Aramark management described "hundreds of millions in annual revenue" from this initiative, with "hundreds of acres, thousands of workers" involved. [S3]

This is a new vertical that blends Business Industry and Facilities Other capabilities and is driving the 18% growth in the Business Industry sub-segment.

6. Competitive Position [S4]

Competitor Revenue Organic Growth Operating Margin US Positioning
Compass Group ~$42B ~10.6% ~7.1% Largest in US; #1 college dining
Sodexo ~$26B ~7.9% ~4-5%? Strong healthcare/seniors
Aramark ~$18.5B ~6-8% ~4.3% #2 US overall
Delaware North ~$5B N/A (private) N/A Sports/entertainment specialist

ARMK trades at a discount to Compass Group on operating margin (4.3% vs 7.1%) — a key debate: structural gap or opportunity for convergence?

7. Customer Concentration & Retention [S1]

  • No single client accounts for more than 10% of revenue (typical for contract services)
  • Education and healthcare contracts are particularly sticky (multi-year, state/grant funding dependent)
  • Net Retention Rate >90% is management-guided; validated by consistent organic growth without major disclosed churn

8. Capital-Light vs Capital-Intensive Assessment

Aramark sits at a moderate capital intensity level:

  • CapEx: $489M in FY2025 (~2.6% of revenue) — primarily for kitchen equipment installation, facility upgrades at new contract sites
  • Goodwill: $4.87B — reflects ~15 years of tuck-in acquisitions
  • Working capital: Seasonal pattern (build in Q1-Q2, release in Q3-Q4 due to sports seasonality)

Not a capital-light SaaS business, but not as capital-intensive as manufacturing. The key financial leverage is operating leverage — as revenue grows, cost absorption spreads.


Source Index

Code Source
[S1] SEC 10-K FY2025 (0001584509-25-000219) — segment details, revenue breakdown
[S2] StockAnalysis.com — ARMK financial statistics (retrieved Jun 2026)
[S3] Aramark investor presentation / analyst day materials (FY2025 results, retrieved Jun 2026)
[S4] Competitive landscape research (industry/competitive_landscape.md, retrieved Jun 2026)

Financial Snapshot


source: coverage-next-full ticker: ARMK company: Aramark step: 04 title: Financial Quality & Adversarial Sweep created: 2026-06-09

Step 04 — Financial Quality & Adversarial Sweep: ARMK (Aramark)

1. Statement Quality Adjustments

Key Adjustments Required for Clean Analysis
Item Reported Adjusted Notes
Net Income FY2023 $674M total $448M cont. ops Must use continuing operations to exclude Vestis disc. ops
Net Income FY2022 $194M total $39M cont. ops Vestis was ~$155M of FY2022 net income
Revenue FY2022–2023 Pre-spin total Cont. ops only Vestis contributed ~$2.7–2.8B/year pre-spin
FY2025 revenue $18.5B $18.0B organic ~2% = 53rd week contribution (one-time)
Adjusted EPS (Street) $1.82 (FY2025) $1.22 GAAP Street "Adjusted EPS" adds back amortization ~$0.60/share; GAAP is the conservative base

Analyst-adjusted EPS vs GAAP: Aramark management and analysts use an "Adjusted EPS" metric that excludes amortization of acquired intangibles (~$0.55–0.65/share) and certain one-time items. This is common in M&A-heavy services companies. GAAP EPS $1.22 vs Adjusted EPS $1.82 in FY2025. The gap is entirely explainable by amortization — not a quality concern, but must be applied consistently when using peer multiples.

Non-Cash Items to Monitor [S1]
Item FY2025 Commentary
D&A $476.4M 2.6% of revenue; large relative to GAAP earnings; goodwill amortization significant
SBC ~$75–80M (est.) Not separately disclosed in XBRL summary; in proxy compensation data; low relative to revenue
Goodwill $4,874.7M ~26% of total assets; largest single balance sheet item; impairment risk if growth slows
Intangibles (net) $1,874.1M Customer relationships, trade names from acquisitions
Working Capital Seasonality [S1]

Aramark's cash flows are highly seasonal:

  • Q1 (Oct–Dec): Large working capital build as new academic year/sports season begins; operating CF negative in some years
  • Q3–Q4 (Apr–Sep): Working capital release; OCF strongest
  • Full-year OCF $921M (FY2025) driven by Q3-Q4 release; misleading to annualize any single quarter

2. Financial Quality Scorecard

Dimension Score Notes
Revenue recognition Clean Service contracts; no complex variable consideration issues flagged
Earnings quality (OCF/NI) Good OCF $921M vs NI $327M = 2.8x; strong conversion confirms earnings quality
Free cash flow generation Improving $432M FCF in FY2025 up from $299M (FY2024) and $128M (FY2023) — clear upward trajectory
Balance sheet quality Moderate $4.9B goodwill + $1.9B intangibles = 51% of total assets intangible; elevated leverage
Debt structure Improving Proactive refinancing removes near-term maturities; ~$2.4B liquidity buffer
Revenue comparability Requires adjustment Pre/post Vestis spin requires continuing-ops normalization
Segment disclosure Good FY2025 10-K discloses US sub-sector revenue breakdown in detail

3. Adversarial Research Sweep [S2][S3]

Note: This research is based on filings, press releases, and publicly available litigation data. No earnings call transcript analysis was performed (coverage-next-full path).

Short Interest & Bearish Arguments
  • Short interest: ~9.71M shares (3.69% of float) — elevated but not extreme [S2]
  • No active short campaigns or major investigative reports identified
  • Bear thesis focuses on: (1) margin ceiling relative to Compass Group, (2) leverage, (3) labor cost inflation sustainability
Legal / Regulatory Investigations
  • No SEC formal investigations identified in filing inventory
  • Standard litigation disclosures in 10-K: employment disputes, commercial contract disagreements — no material items flagged by management
  • Food safety incidents: No systemic food safety recalls or FDA enforcement actions found in public record
Accounting / Audit Concerns
  • Auditor: Deloitte & Touche LLP (consistent; no auditor change flagged)
  • Going concern: Not flagged
  • Internal controls: Material weakness? None found in FY2022–FY2025 10-K disclosures
  • Revenue recognition: No restatements; no SEC comment letters related to revenue methodology in recent filings (3-year look-back)
Governance / Activist Concerns
  • No active activist campaigns identified
  • Board declassified (annual elections) — positive governance signal
  • CEO succession note: $5M retention RSU awarded to CEO Zillmer in FY2025 with explicit succession context — suggests transition planning underway but no near-term leadership risk [S3]
Key Creditor Risk (Leverage)
  • Interest coverage 2.48x (TTM) [S2] — thin but improving as EBITDA grows
  • Debt/EBITDA TTM ~4.5x (declining; management targeting ≤3.0x which was achieved in FY2025 per guidance)
  • Most near-term maturities refinanced in FY2025 — next major maturity wall manageable
  • Key risk: A revenue decline of 10%+ or margin compression back to FY2021 levels (~1.6% operating margin) would pressure covenant ratios. COVID scenario (FY2020: revenues fell 21%) is the tail risk.
Supplier Concentration Risk [S1]
  • Sysco provides ~45% of US and Canada food distribution for Aramark — disclosed in 10-K risk factors
  • Single-supplier concentration for nearly half of food supply is a real operational risk
  • Partially mitigated by: Aramark's purchasing scale (favorable pricing leverage), Sysco's financial stability, national distribution reach

4. FCF Quality & Sustainability [S1][S2]

Year OCF CapEx FCF FCF Margin
FY2021 ~$450M ~$280M ~$170M 1.4%
FY2022 ~$600M ~$350M ~$250M 1.8%
FY2023 ~$450M ~$322M ~$128M 0.8%
FY2024 $726.5M $427.4M $299M 1.7%
FY2025 $921.0M $489.2M $432M 2.3%
TTM ~$490M (est.) ~2.5%

FCF trajectory is clearly improving. FY2023 was depressed by transaction costs (Vestis spin) and integration expenses. FY2024–2025 reflects the clean post-spin base. The path to $600–700M FCF by FY2027 requires continued EBITDA growth (+$150M) and stable CapEx (~2.5% of revenue), which appears achievable at guided growth rates.

CapEx growing to $489M (+15% YoY) reflects accelerated new contract investment — including Nexus data center setups. This is growth capex, not maintenance. Management separates maintenance capex (~1.5% of revenue) from growth capex.


Source Index

Code Source
[S1] SEC 10-K FY2025 (0001584509-25-000219); XBRL financial data
[S2] StockAnalysis.com — ARMK statistics, short interest (retrieved Jun 2026)
[S3] SEC Proxy DEF 14A 2025 — CEO compensation, governance

Recent Catalysts


source: coverage-next-full ticker: ARMK company: Aramark step: 12 title: Bull vs. Bear — Analyst Debate created: 2026-06-09

Step 12 — Bull vs. Bear Catalyst Analysis: ARMK (Aramark)

Note: Earnings call transcript analysis not performed (coverage-next-full path). Bull/bear debate reconstructed from analyst notes, consensus data, investor presentations, and 10-K filings. The analyst debate framework is applied to available public materials.

1. The Core Debate

At ~$52.82/share and 14x EV/EBITDA, the market is pricing Aramark as a mid-cycle inflection story — post-spin, deleveraging, organic growth on track. The debate is:

Bulls: ARMK is at an operating leverage inflection point. The combination of Aramark Nexus (new data center vertical), RWJ Barnabas ramp, international acceleration, and FCF compounding will drive EPS from $1.82 (FY2025 adj.) to $2.50+ by FY2027 — and multiple expansion from 14x to 16-18x EV/EBITDA as leverage falls to 2.5x. Total return: 40-60% over 3 years.

Bears: The margin ceiling is structural (labor-intensive services; Compass already captures the margin expansion premium). ARMK will struggle to close the gap to Compass's 7.1% margin from 4.3%. Nexus is early and execution-dependent. The stock at 14x EV/EBITDA is fair value for a thin-margin services company — upside is capped at modest re-rating.

2. Bull Case Arguments [S1][S2][S3]

Bull 1: Aramark Nexus is a Structural Growth Catalyst Not Priced In

Aramark Nexus — dedicated food and facilities services for AI hyperscaler data centers — is the most underdiscounted element of the investment case. Management describes "hundreds of millions" in annual revenue potential, and the Business Industry sub-sector grew +18% in FY2025 (vs +4.5% in FY2024), implying ~$250–300M in Nexus-attributable revenue already. [S1]

Data center campuses require 24/7 food service for thousands of engineers and construction workers across hundreds of acres. These are long-term, captive contracts with minimal competitive pressure at inception. Margin profile is at least B&I average (5–6% contribution); likely better given higher employee density and minimal competitive bidding frequency.

Bull case for Nexus: Reaches $500M+ annual run-rate by FY2027, adding ~100 bps to organic growth above base guidance. At B&I margins, this implies ~$30–35M incremental operating income. [S3]

Bull 2: RWJ Barnabas Health Creates Visible FY2026 Revenue Upside

The RWJ Barnabas Health contract — one of New Jersey's largest hospital systems — began ramping ahead of schedule in early Q2 FY2026. [S2] This is a large healthcare services contract that:

  • Provides contracted revenue visibility for 5+ years
  • Contributes to the +8.5% Q2 FY2026 organic growth (ahead of consensus)
  • Validates Aramark's healthcare segment competitive positioning

9 analysts raised price targets following Q2 FY2026 earnings (May 13, 2026), citing RWJ Barnabas as the primary positive surprise. [S2]

Bull 3: FCF Compounding Funds De-leveraging and Capital Return

FCF trajectory: $128M (FY2023) → $299M (FY2024) → $432M (FY2025) — tripling in two years. Management's FY2026 guidance implies AOI +12-17%, suggesting FCF of ~$550-650M. [S3]

At $600M FCF, ARMK generates a 4.3% FCF yield on market cap (~$13.9B) — the beginning of meaningful capital return. $200M buybacks + $130M dividends = $330M returned, leaving $270M for further deleverage. By FY2027, if leverage reaches 2.5x (vs. 3.0x today), a re-rating from 14x to 16x EV/EBITDA is plausible (+15% multiple expansion).

3. Bear Case Arguments [S1][S2][S4]

Bear 1: Structural Margin Ceiling — The Compass Gap is Not Closeable

Compass Group operates at 7.1% operating margin vs. ARMK's 4.3% — a 280 bps gap. Bears argue this gap is structural, not cyclical:

  • Labor intensity: Aramark employs more labor-intensive contracts (healthcare, education, corrections) vs. Compass's higher-margin technology/premium dining exposure
  • Scale discount: Compass at $42B revenue has materially better purchasing economics than ARMK at $18.5B
  • Management track record: ARMK has improved margins ~160 bps over FY2021-FY2025 — a 40 bps/year rate. At this pace, reaching 5.5% would take 3 more years and require no macro headwinds

Bear case: ARMK's target margin ceiling is ~5.5-6.0%, not Compass's 7.1%. At 5.5% operating margin, EBITDA margin is ~8.0% — implying EBITDA of ~$1.6B (FY2026 at +8% revenue). At 14x EV/EBITDA = $22.4B EV; less $5.5B net debt = $16.9B equity / 262M shares = ~$64. Marginal upside only. [S4]

Bear 2: Nexus Execution Risk and Newness Premium

Aramark Nexus is exciting but:

  • The hyperscaler client is unnamed (limiting verification)
  • "Hundreds of millions" could be 2-3 years from full realization
  • Data center food services require managing large, distributed, often remote campuses — operationally complex and new for ARMK
  • Early-stage contracts may include higher capital commitments and ramp risk (new account startup costs press initial margins)

Bear case: Nexus disappoints or ramps slower than expected; the 18% B&I growth normalizes to 8-10% by FY2027; EPS estimates come down. [S1]

Bear 3: Labor Cost Inflation Persistently Outpaces Escalators

State-level minimum wage increases continue: California's $20/hr food-service minimum (April 2024), other states following. With ~42% of costs in labor and ~278,000 employees, a 3% labor cost increase = ~$232M annual headwind. Price escalators (CPI-linked, typically 1-6 months lag) offset only partially.

If labor inflation runs at 3-4% and price escalation at 2-3%, the net annual drag is 20-40 bps on margins. Over 3 years, this becomes 60-120 bps of structural compression — offsetting much of the operating leverage benefit. [S1]

4. Consensus Positioning [S2]

Category Count % Implication
Strong Buy / Buy 14 87.5% Consensus is bullish
Hold 2 12.5% Few skeptics
Sell / Strong Sell 0 0% No formal bears
Average Price Target $54.50–55.44 ~3-5% above current ~$52.82
Bull Target $63 (Citi) +19% upside
Bear Target $40 (low) -24% downside

Consensus is crowded long. Virtually all analysts are at Buy/Strong Buy. This creates a risk of consensus disappointment if FY2026 organic growth comes in at the low end of guidance (5-7% vs 7-9% guided). The stock is not cheap enough (14x EV/EBITDA) to absorb a negative guidance revision without a 15-20% correction.

5. Key Earnings Catalysts (Near-Term, 12 Months) [S2][S3]

Catalyst Timing Bull Outcome Bear Outcome
Q3 FY2026 Earnings ~Aug 2026 Organic +9-10%; RWJ Barnabas full ramp; Nexus growth Organic disappoints at 5-6%; margin misses
FY2026 Annual Guidance Reiteration ~Nov 2026 EPS +20-25% on track; leverage at 2.8x Guidance cut; EPS growth falls to 10-15%
Nexus client announcement Potentially FY2026 Major hyperscaler named; validates Nexus as $500M+ vertical No announcement; "hundreds of millions" fades as narrative
Leverage milestone FY2026 year-end Net Debt/EBITDA reaches 2.5-2.7x; sets up IG rating aspiration Leverage stalls at 3.0x; capital return pace disappoints
Buyback acceleration Q3-Q4 FY2026 $330M remaining deployed rapidly; announces $500M new program Buybacks slow; capital allocated to acquisitions or debt

Bull Case — 3 Bullets

  • Aramark Nexus + RWJ Barnabas create visible multi-year organic growth above consensus: The Business Industry segment (+18% FY2025) has new structural demand from AI data center buildout; RWJ Barnabas validates healthcare win engine; combined these catalysts support 8-10% organic growth through FY2027, ahead of the 7-9% street consensus.
  • FCF inflection unlocks capital return cycle: FCF tripled from $128M to $432M in two years; path to $600M+ (FY2026-27) at current growth rates creates a 4-5% FCF yield that funds buybacks, dividend raises, and deleverage simultaneously — a classic capital return flywheel in early innings.
  • Multiple expansion from de-leveraging + margin convergence toward Compass Group: Every 0.5x leverage reduction expands the EV/equity value per share ~$5; if ARMK margin trajectory reaches 5.5% operating margin by FY2027 (vs 4.3% today), combined with deleverage, the stock is worth $70-80 on consensus EPS of $2.50-3.00 at 15-17x forward P/E.

Bear Case — 3 Bullets

  • Structural margin ceiling at ~5.5% makes the stock fairly valued at current price: The Compass Group margin gap (4.3% vs 7.1%) reflects structural differences in contract mix, labor intensity, and scale — not a temporary catch-up opportunity; at a realistic margin ceiling of 5.5-6.0%, ARMK is worth ~$55-65, implying limited upside from $52.82 current.
  • Labor cost inflation at 3-4% per year persistently outpaces price escalators: With 42% of costs in labor and state minimum wages escalating, the 20-40 bps annual margin drag will offset operating leverage benefits, making the path to >5% operating margins slower than the Street assumes; a guidance cut in FY2026 would trigger a 15-20% multiple compression.
  • Nexus execution risk and consensus long positioning create asymmetric downside: Virtually all analysts are at Buy with narrow average upside (3-5%); if Nexus ramps slower than guided or the unnamed hyperscaler reduces scope, the narrative catalyst disappears and the stock re-rates to 12-13x EV/EBITDA (Sodexo valuation) = ~$40-45.

Source Index

Code Source
[S1] SEC 10-K FY2025 (0001584509-25-000219) — segment data, cost structure, risk factors
[S2] Street consensus + analyst notes (other/consensus.md)
[S3] Investor presentation FY2025 (presentations/investor_presentation_2024.md)
[S4] Competitive landscape (industry/competitive_landscape.md)

Full Research Available

This primer covers steps 1–3 of 21. The full deep dive includes moat analysis, DCF valuation, bull/bear scenarios, management quality, earnings transcript analysis, competitive positioning, returns on capital, institutional/insider activity, and an investment memo.

View Investment MemoEach memo is $2. Coverage subscriptions for funds coming soon — join the waitlist.